AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

ADMA Biologics Inc. (ADMA)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

16.22

0.32 (2.01%)

At close: Feb 18, 2025, 3:59 PM

16.17

-0.31%

After-hours: Feb 18, 2025, 04:09 PM EST

undefined% (undefined)

Bid	16.17
Market Cap	3.83B
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	0.27
PE Ratio (ttm)	60.07
Forward PE	n/a
Analyst	Strong Buy

Ask	16.5
Volume	1,491,997
Avg. Volume (20D)	2,396,250
Open	16.08
Previous Close	15.90
Day's Range	16.02 - 16.56
52-Week Range	5.02 - 23.64
Beta	undefined

About ADMA

ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB for the ...

[Show more]

Industry Biotechnology

Sector Healthcare

IPO Date Oct 17, 2013

Employees 624

Stock Exchange NASDAQ

Ticker Symbol ADMA

Website https://www.admabiologics.com

Full Company Profile

Analyst Forecast

According to 4 analyst ratings, the average rating for ADMA stock is "Strong Buy." The 12-month stock price forecast is $22.5, which is an increase of 38.72% from the latest price.

Buy 100.00%

Hold 0.00%

Sell 0.00%

Stock Forecasts

Next Earnings Release

ADMA Biologics Inc. is scheduled to release its earnings on Mar 3, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

1 month ago

-11.15%

ADMA Biologics shares are trading lower. The compa... Unlock content with Pro Subscription

3 months ago

+14.71%

ADMA Biologics shares are trading higher after the company reported better-than-expected Q3 financial results and raised its FY24 and FY25 revenue guidance.

News

1 week ago · schaeffersresearch.com

Pharma Stock Poised to Bounce Off Support

Pharmaceutical concern ADMA Biologics Inc (NASDAQ:ADMA) has been consolidating above familiar pressure at the $16 region since mid-January.

1 week ago · zacks.com

ADMA Loses 8.9% in a Month: How Should You Play the Stock?

ADMA Biologics' shares lose 8.9% in a month after putting up a phenomenal performance in the past 12 months. While the prospects remain sound, the exceptional rally witnessed by the stock might limit ...

1 week ago · zacks.com

Adma Biologics (ADMA) Advances But Underperforms Market: Key Facts

In the closing of the recent trading day, Adma Biologics (ADMA) stood at $16.92, denoting a +0.3% change from the preceding trading day.

1 week ago · seekingalpha.com

ADMA Biologics: Recent Pullback Is A Perfect Opportunity To Add

ADMA Biologics specializes in primary immune deficiencies with Asceniv, a high-margin, unique product that outperforms competitors and has significant growth potential in the U.S. market. Asceniv's hi...

2 weeks ago · zacks.com

Adma Biologics (ADMA) Ascends While Market Falls: Some Facts to Note

Adma Biologics (ADMA) concluded the recent trading session at $16.47, signifying a +1.98% move from its prior day's close.

3 weeks ago · zacks.com

Adma Biologics (ADMA) Stock Declines While Market Improves: Some Information for Investors

Adma Biologics (ADMA) closed the most recent trading day at $16.17, moving -0.12% from the previous trading session.

4 weeks ago · zacks.com

Adma Biologics (ADMA) Rises Higher Than Market: Key Facts

Adma Biologics (ADMA) concluded the recent trading session at $16.47, signifying a +1.92% move from its prior day's close.

4 weeks ago · marketbeat.com

There May Still Be Time to Get in on These 3 Trending Biotechs

Despite the strength of the economy overall, 2024 was a challenging year for the biotech industry. The high cost of borrowing—particularly prior to the Fed's first rate cut in several years in Septemb...

1 month ago · zacks.com

Adma Biologics (ADMA) Stock Sinks As Market Gains: Here's Why

The latest trading day saw Adma Biologics (ADMA) settling at $16.32, representing a -1.03% change from its previous close.

1 month ago · zacks.com

ADMA Stock Catapults 275.7% in a Year: How Should You Play the Stock?

ADMA Biologics performance in the past twelve months has been phenomenal. While the prospects remain sound, the exceptional rally witnessed by the stock might limit any further gain.

Load More News